Jump to content
  • Sign Up
×
×
  • Create New...

No reports of counterfeit Ozempic in Canada amid WHO warning – National


Recommended Posts

  • Diamond Member



No reports of counterfeit Ozempic in Canada amid WHO warning – National

Health Canada says it has not received any reports of counterfeit Ozempic in the country after the World Health Organization issued a warning about fake batches of the popular diabetes ***** detected in some countries.

This is the hidden content, please
was about three falsified lots of Ozempic that were detected in the ******* States in December 2023, and the ******* Kingdom and Brazil in October 2023.

These fake injections, which were found in the regulated supply chain, misrepresent their identity and source as they were not manufactured by Ozempic maker Novo Nordisk,

This is the hidden content, please

Using counterfeit Ozempic may result in “ineffective treatment” and may also pose other serious health risks that could be “life-threatening,” the WHO said.

Tammy Jarbeau, a Health Canada spokesperson, told Global News in an emailed statement on Thursday that the agency was aware of cases of counterfeit Ozempic pens in other countries.

Story continues below advertisement

“Health Canada works in partnership with the Canada Border Services Agency to detect and stop unauthorized health products from entering the country,” Jarbeau said.


The latest health and medical news
emailed to you every Sunday.

“To date, the department has not received any reports or complaints of counterfeit Ozempic in Canada.”


This is the hidden content, please
/applications/core/interface/js/spacer.png">


Ozempic-makers’ weight-loss *****, Wegovy, coming soon to Canada


In recent years, Canada, like other countries, has seen high demand for medications like Ozempic, which is primarily approved for the treatment of Type 2 diabetes but has been used off-label for weight loss.

Wegovy, an on-label weight loss medication containing the same ***** as Ozempic but at a higher formulation and made by the same manufacturer, also recently became available to Canadians.

In its warning Thursday, the WHO said it has been observing increased reports of falsified semaglutides – the pharmaceutical name for the ***** in both Ozempic and Wegovy – in all geographic regions since 2022.

Story continues below advertisement

“WHO advises healthcare professionals, regulatory authorities and the public be aware of these falsified batches of medicines,” said Yukiko Nakatani, the WHO’s assistant director-general for access to medicines and health products.

“We call on stakeholders to stop any usage of suspicious medicines and report to relevant authorities.”

To avoid any risks, Health Canada urged Canadians to get their medicines from a licensed pharmacy, only buy products that are authorized for ***** and avoid buying products from unlicensed and unverified online sellers.


This is the hidden content, please
/applications/core/interface/js/spacer.png">


What are ‘Ozempic *******’ and why are women reporting being pregnant while on weight-loss drugs?


&copy 2024 Global News, a division of Corus Entertainment Inc.







This is the hidden content, please

Ozempic, Health Canada, semaglutide, WHO, Canada, Health
#reports #counterfeit #Ozempic #Canada #warning #National

This is the hidden content, please

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Unfortunately, your content contains terms that we do not allow. Please edit your content to remove the highlighted words below.
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Vote for the server

    To vote for this server you must login.

    Jim Carrey Flirting GIF

  • Recently Browsing   0 members

    • No registered users viewing this page.

Important Information

Privacy Notice: We utilize cookies to optimize your browsing experience and analyze website traffic. By consenting, you acknowledge and agree to our Cookie Policy, ensuring your privacy preferences are respected.